Psyllium fiber improves glycemic control proportional to loss of glycemic control: A meta-analysis of data in euglycemic subjects, patients at risk of type 2 diabetes mellitus, and patients being treated for type 2 diabetes mellitus

American Journal of Clinical Nutrition

Volumn 102, Issue 6, 2015, Pages 1604-1614

  Gibb, Roger D ^a   McRorie, Johnson W ^a   Russell, Darrell A ^a   Hasselblad, Vic ^b   D'Alessio, David A ^b  

^a PROCTER AND GAMBLE COMPANY   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; Fiber; Glycemic; Glycemic control; Meta analysis; Metabolic syndrome; Psyllium; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; HEMOGLOBIN A1C; ISPAGULA; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; PREBIOTIC AGENT;

ANTIDIABETIC ACTIVITY; ARTICLE; CONTROLLED CLINICAL TRIAL (TOPIC); DRUG EFFECT; GEL; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN RESPONSE; LIFESTYLE MODIFICATION; META ANALYSIS; MUCILAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; PLANTAGO; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SYSTEMATIC REVIEW; ADVERSE EFFECTS; BLOOD; DIABETES MELLITUS, TYPE 2; DIET THERAPY; EVIDENCE BASED MEDICINE; HYPERGLYCEMIA; HYPOGLYCEMIA; MULTIMODALITY CANCER THERAPY; PREDIABETIC STATE; RISK;

COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 2; EVIDENCE-BASED MEDICINE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; PREBIOTICS; PREDIABETIC STATE; PSYLLIUM; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK;

EID: 84948799620     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.115.106989     Document Type: Article

References (47)

1. Institute of Medicine (IOM), Food and Nutrition Board. Dietary Reference Intakes: energy, carbohydrates, fiber, fat, fatty acids cholesterol, protein and amino acids. Washington, DC: National Academies Press; 2002
2. McRorie JW. Evidence-based approach to fiber supplements and clinically meaningful health benefits, part 1: what to look for and how to recommend an effective fiber therapy. Nutr Today 2015;50:82-9
3. McRorie JW. Evidence-based approach to fiber supplements and clinically meaningful health benefits, part 2: what to look for and how to recommend an effective fiber therapy. Nutr Today 2015;50:90-7
4. McRorie J, Fahey G. Fiber supplements and clinically meaningful health benefits: identifying the physiochemical characteristics of fiber that drive specific physiologic effects. In: Wallace TC, editor. The CRC handbook on dietary supplements in health promotion. Boca Raton (FL): CRC Press, Tayor &Francis Group; 2015. p. 162-95
5. Jenkins DJ, Wolever T, Leeds A, Gassull M, Haisman P, Dilawari J. Dietary fibres, fibre analogues, and glucose tolerance: importance of viscosity. BMJ 1978;1:1392-4
6. Chutkan R, Fahey G, Wright W, McRorie J. Viscous versus nonviscous soluble fiber supplements: Mechanisms and evidence for fiberspecific health benefits. J Am Acad Nurse Pract 2012;24:476-87
7. McRorie J, Fahey G. A review of gastrointestinal physiology and the mechanisms underlying the health benefits of dietary fiber: matching an effective fiber with specific patient needs. Clinical Nursing Studies 2013;1:82-92
8. Goke B, Herrmann C, Goke R, Fehmann H, Berghofer P, Richter G, Arnold R. Intestinal effects of alpha-glucosidase inhibitors: absorption of nutrients and enterohormonal changes. Eur J Clin Invest 1994;24 (Suppl 3):25-30
9. Goke B, Fuder H,Wieckhorst G, Theiss U, Stridde E, Littke T, Kleist P, Arnold R, Lucker P. Voglibose (AO-128) is an efficient alphaglucosidase inhibitor and mobilizes the endogenous GLP-1 reserve. Digestion 1995;56:493-501
10. Sartor G, Carlstrom S, Scherstén B. Dietary supplementation of fibre (Lunelax) as a means to reduce postprandial glucose in diabetics. Acta Med Scand Suppl 1981;656:51-3
11. Jarjis HA, Blackburn N, Redfern J, Read N. The effect of ispaghula (Fybogel and Metamucil) and guar gum on glucose tolerance in man. Br J Nutr 1984;51:371-8
12. Wolever Tm, Vuksan V, Eshuis H, Spadafora P, Peterson R, Chao E, Storey M, Jenkins D. Effect of method of administration of psyllium on glycemic response and carbohydrate digestibility. J Am Coll Nutr 1991;10:364-71
13. Frati-Munari AC, Benítez Pinto W, Rau Ariza Andraca C, Casarrubias M. Lowering glycemic index of food by acarbose and Plantago psyllium mucilage. Arch Med Res 1998;29:137-41
14. Dastjerdi M, Salehion M, Najafian A, Amini M. A randomized controlled study for evaluation of psyllium effects on kinetics of carbohydrate absorption. J Res Med Sci 2007;12:125-30
15. Pastors JG, Blaisdell P, Balm T, Asplin C, Pohl S. Psyllium fiber reduces rise in postprandial glucose and insulin concentrations in patients with non-insulin-dependent diabetes. Am J Clin Nutr 1991;53:1431-5
16. Rodríguez-Morán M, Guerrero-Romero F, Laczano-Burciaga L. Lipid-and glucose-lowering efficacy of Plantago psyllium in type II diabetes. J Diabetes Complications 1998;12:273-8
17. Anderson JW, Allgood L, Turner C, Oelgten P, Daggy B. Effects of psyllium on glucose and serum lipid responses in men with type 2 diabetes and hypercholesterolemia. Am J Clin Nutr 1999;70:466-73
18. Ziai SA, Larijani B, Akhoondzadeh S, Fakhzadeh H, Dastpak A, Bandarian F. Psyllium decreased serum glucose and glycosylated hemoglobin significantly in diabetic outpatients. J Ethnopharmacol 2005; 102:202-7
19. Feinglos M, Gibb R, Ramsey D, Surwit R, McRorie J. Psyllium improves glycemic control in patients with type-2 diabetes mellitus. Bioactive Carbohydrates and Dietary Fibre 2013;1:156-61
20. Anderson JW, Zettwoch N, Feldman T, Tietyen-Clark J, Oeltgen P, Bishop C. Cholesterol-lowering effects of psyllium hydrophilic mucilloid for hypercholetserolemic men. Arch Intern Med 1988;148:292-6
21. Bell LP, Hectorne K, Reynolds H, Balm T, Hunninghake D. Cholesterol-lowering effects of psyllium hydrophilic mucilloid. Adjunct therapy to a prudent diet for patients with mild to moderate hypercholesterolemia. JAMA 1989;261:3419-23
22. Cicero A, Derosa G, Bove M, Imola F, Borghi C, Gaddi A. Psyllium improves dyslipidemaemia, hyperglycaemia and hypertension, while guar gum reduces body weight more rapidly in patients affected by metabolic syndrome following an AHA Step 2 diet. Med J Nutrition Metab 2010;3:47-54
23. Lu C, Lee W, Wang J. Clinical assessment of the effects of psyllium on weight control and the lipid profile of obese adults. Nutr Sci J 2012;37: 136-46
24. de Bock M, Derraik J, Brennan C, Biggs J, Smith G, Cameron-Smith D, Wall C, Cutfield W. Psyllium supplementation in adolescents improves fat distribution &lipid profile: a randomized, participantblinded, placebo-controlled, crossover trial. PLoS One 2012;7:e41735
25. Frati-Munari AC, Flores-Garduño M, Ariza-Andraca R, Islas-Andrade S, Chávez Negrete A. Effect of different doses of Plantago psyllium mucilage on the glucose tolerance test. Arch Invest Med (Mex) 1989; 20:147-52
26. Cherbut C, Des Varannes S, Schee M. Involvement in small intestinal motility in blood glucose response to dietary fibre in man. Br J Nutr 1994;71:675-85
27. Rigaud D, Paycha F, Meulemans A, Merrouche M, Mignon M. Effect of psyllium on gastric emptying, hunger feeling and food intake in normal volunteers: a double blind study. Eur J Clin Nutr 1998;52:239-45
28. Sierra M, Garcia JJ, Fernández N, Diez MJ, Calle AP, Sahagun AM. Effects of ispaghula husk and guar gum on postprandial glucose and insulin concentrations in healthy subjects. Eur J Clin Nutr 2001;55: 235-43
29. Frost GS, Byrnes A, Dhillo W. The effects of fiber enrichment of pasta and fat content on gastric emptying, GLP-1, glucose and insulin response to a meal. Eur J Clin Nutr 2003;57:293-8
30. Karhunen LJ, Juvonen K, Flander S. A psyllium fiber-enriched meal strongly attenuates postprandial gastrointestinal peptide release in healthy young adults. J Nutr 2010;140:737-44
31. Anderson JW, Davidson M, Blonde L, Brown W, Howard W, Ginsberg H, Allgood L, Weingand K. Long-term cholesterol-lowering effects of psyllium as an adjunct to diet therapy in the treatment of hypercholesterolemia. Am J Clin Nutr 2000;71:1433-8
32. Levin EG, Miller V, Muesing R, Stoy D, Balm T, LaRosa J. Comparison of psyllium hydrophilic mucilloid and cellulose as adjuncts to a prudent diet in the treatment of mild to moderate hypercholesterolemia. Arch Intern Med 1990;150:1822-7
33. Sprecher DL, Harris B, Goldberg A. Efficacy of psyllium in reducing serum cholesterol levels in hypercholesterolemic patients on high-and low-fat diets. Ann Intern Med 1993;119:545-54
34. Riley RD, Lambert P, Staessen J, Wang J, Guevffier F, Thijs L, Boutitie F. Meta-analysis of continuous outcomes combining individual patient data and aggregate data. Stat Med 2008;27:1870-93
35. Knowler WC, Barrett-Connor E, Fowler S, Hamman R, Lachin J, Walker E, Nathan D. Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403
36. Rimm EB, Ascherio A, Giovannucci E, Spiegelman D, Stampfer M, Willett W. Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. JAMA 1996;275:447-51
37. Mozaffarian D, Kumanyika S, Lemaitre R, Olson J, Burke G, Siscovick D. Cereal, fruit, and vegetable fiber intake and the risk of cardiovascular disease in elderly individuals. JAMA 2003;289:1659-66
38. US Department of Health and Human Services, US Department of Agriculture. Dietary guidelines for Americans. Washington (DC): Government Printing Office; 2010
39. Wolever TM, Tosh S, Gibbs A, Brand-Miller J. Physicochemical properties of oat b-glucan influence its ability to reduce serum LDL cholesterol in humans: a randomized clinical trial. Am J Clin Nutr 2010;92:723-32
40. Vuksan V, Jenkins A, Rogovik A, Fairgrieve C, Jovanovski E, Leiter L. Viscosity rather than quantity of dietary fibre predicts cholesterol-lowering effect in healthy individuals. Br J Nutr 2011; 106:1349-52
41. Qualmann C, Nauck MA, Holst JJ, Orskov C, Creutzfeldt W. Glucagon-like peptide 1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using alpha-glucosidase inhibition (acarbose). Scand J Gastroenterol 1995;30:892-6
42. Sakurai K, Lee E, Morita A, Kimura S, Kawamura H, Kasamatsu A, Shiiba M, Yabe D, Yokote K, Miki T. Glucagon-like peptide-1 secretion by direct stimulation of L cells with luminal sugar vs non-nutritive sweetener. J Diabetes Investig 2012;3:156-63
43. Schirra J, Goke B. The physiological role of GLP-1 in human: incretin, ileal brake or more? Regul Pept 2005;128:109-15
44. McRorie J. Clinical data support that psyllium is not fermented in the gut. Am J Gastroenterol 2013;108:1541
45. Brandt LJ, Prather C, Quigley E, Schiller L, Schoenfeld P, Talley N. Systematic review on the management of chronic constipation in North America. Am J Gastroenterol 2005;100(Suppl 1):S5-21
46. Eswaran S, Muir J, Chey W. Fiber and functional gastrointestinal disorders. Am J Gastroenterol 2013;108:718-27
47. Luther J, Chey W. Psyllium increased symptom relief in patients with the irritable bowel syndrome more than bran or placebo. Ann Intern Med 2010;152:JC1-11